| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;110:1909-1915.)
© 2004 American Heart Association, Inc.
Coronary Heart Disease |
From Service de Cardiologie, Hôpital Européen Georges Pompidou, Paris (N.D.); Clinique St Gatien, Tours (D.B.); Hôpital Bichat, Paris (P.G.S.); Hôpital Necker, Paris (P.S.); Centre Hospitalier dAulnay, Aulnay (G.H.); Centre Hospitalier Régional Universitaire de Lille, Lille (P. Goldstein, J.-M.L.); INSERM U 558, Toulouse (J.-P.C.); Hôpital Henri Mondor, Créteil (P. Guéret); and Laboratoire Aventis, Paris (L.V., Y.B., N.G.), France.
Correspondence to Nicolas Danchin, MD, FESC, FACC, Service de Cardiologie, Hôpital Européen Georges Pompidou, 20 Rue Leblanc, 75015 Paris, France. E-mail nicolas.danchin{at}egp.ap-hop-paris.fr
Received March 25, 2004; de novo received May 5, 2004; revision received June 9, 2004; accepted June 10, 2004.
Background Limited data are available on the impact of prehospital thrombolysis (PHT) in the "real-world" setting.
Methods and Results Of 443 intensive care units in France, 369 (83%) prospectively collected all cases of infarction (
48 hours of symptom onset) in November 2000; 1922 patients (median age, 67 years; 73% men) with ST-segmentelevation infarction were included, of whom 180 (9%) received intravenous thrombolysis before hospital admission (PHT). Patients with PHT were younger than those with in-hospital thrombolysis, primary percutaneous interventions, or no reperfusion therapy. Median time from symptom onset to hospital admission was 3.6 hours for PHT, 3.5 hours for in-hospital lysis, 3.2 hours for primary percutaneous interventions, and 12 hours for no reperfusion therapy. In-hospital death was 3.3% for PHT, 8.0% for in-hospital lysis, 6.7% for primary percutaneous interventions, and 12.2% for no reperfusion therapy. One-year survival was 94%, 89%, 89%, and 79%, respectively. In a multivariate analysis of predictors of 1-year survival, PHT was associated with a 0.49 relative risk of death (95% CI, 0.24 to 1.00; P=0.05). When the analysis was limited to patients receiving reperfusion therapy, the relative risk of death for PHT was 0.52 (95% CI, 0.25 to 1.08; P=0.08). In patients with PHT admitted in
3.5 hours, in-hospital mortality was 0% and 1-year survival was 99%.
Conclusions The 1-year outcome of patients treated with PHT compares favorably with that of patients treated with other modes of reperfusion therapy; this favorable trend persists after multivariate adjustment. Patients with PHT admitted very early have a very high 1-year survival rate.
Key Words: outcome assessment intensive care myocardial infarction thrombolysis
This article has been cited by other articles:
![]() |
H. D. White Systems of Care: Need for Hub-and-Spoke Systems for Both Primary and Systematic Percutaneous Coronary Intervention After Fibrinolysis Circulation, July 15, 2008; 118(3): 219 - 222. [Full Text] [PDF] |
||||
![]() |
N. Danchin, P. Coste, J. Ferrieres, P.-G. Steg, Y. Cottin, D. Blanchard, L. Belle, B. Ritz, G. Kirkorian, M. Angioi, et al. Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention With Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Acute Myocardial Infarction: Data From the French Registry on Acute ST-Elevation Myocardial Infarction (FAST-MI) Circulation, July 15, 2008; 118(3): 268 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
A T Ratcliffe and C Pepper Thrombolysis or primary angioplasty? Reperfusion therapy for myocardial infarction in the UK Postgrad. Med. J., February 1, 2008; 84(988): 73 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Boden, K. Eagle, and C. B. Granger Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction: A Comprehensive Review of Contemporary Management Options J. Am. Coll. Cardiol., September 4, 2007; 50(10): 917 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Kiernan, H. H. Ting, and B. J. Gersh Facilitated percutaneous coronary intervention: current concepts, promises, and pitfalls Eur. Heart J., July 1, 2007; 28(13): 1545 - 1553. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Labarere, L. Belle, M. Fourny, N. Genes, J.-M. Lablanche, D. Blanchard, J.-P. Cambou, N. Danchin, and for the Unite de Soins Intensifs Coronaires 2000 I Outcomes of Myocardial Infarction in Hospitals With Percutaneous Coronary Intervention Facilities Arch Intern Med, May 14, 2007; 167(9): 913 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Stenestrand, J. Lindback, L. Wallentin, and for the RIKS-HIA Registry Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA, October 11, 2006; 296(14): 1749 - 1756. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Armstrong and WEST Steering Committee A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study Eur. Heart J., July 1, 2006; 27(13): 1530 - 1538. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Steg and N. Danchin WEST: new data on the integration of early thrombolysis and mechanical intervention in the early management of STEMI Eur. Heart J., July 1, 2006; 27(13): 1511 - 1512. [Full Text] [PDF] |
||||
![]() |
Z Kadri, N Danchin, L Vaur, Y Cottin, P Gueret, M Zeller, J-M Lablanche, D Blanchard, G Hanania, N Genes, et al. Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study Heart, July 1, 2006; 92(7): 910 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W.A. Verheugt Reperfusion Therapy Starts in the Ambulance Circulation, May 23, 2006; 113(20): 2377 - 2379. [Full Text] [PDF] |
||||
![]() |
K. Kalla, G. Christ, R. Karnik, R. Malzer, G. Norman, H. Prachar, W. Schreiber, G. Unger, H. D. Glogar, A. Kaff, et al. Implementation of Guidelines Improves the Standard of Care: The Viennese Registry on Reperfusion Strategies in ST-Elevation Myocardial Infarction (Vienna STEMI Registry) Circulation, May 23, 2006; 113(20): 2398 - 2405. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Danchin Should intravenous thrombolysis keep a place in the treatment of acute ST-elevation myocardial infarction? Eur. Heart J., May 2, 2006; 27(10): 1131 - 1133. [Full Text] [PDF] |
||||
![]() |
E. Bjorklund, U. Stenestrand, J. Lindback, L. Svensson, L. Wallentin, B. Lindahl, and on behalf of the RIKS-HIA Investigators Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction Eur. Heart J., May 2, 2006; 27(10): 1146 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
The American Heart Association's Acute Myocardial, A. K. Jacobs, E. M. Antman, G. Ellrodt, D. P. Faxon, T. Gregory, G. A. Mensah, P. Moyer, J. Ornato, E. D. Peterson, et al. Recommendation to Develop Strategies to Increase the Number of ST-Segment-Elevation Myocardial Infarction Patients With Timely Access to Primary Percutaneous Coronary Intervention Circulation, May 2, 2006; 113(17): 2152 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Bassand, N. Danchin, G. Filippatos, A. Gitt, C. Hamm, S. Silber, M. Tubaro, and F. Weidinger Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology Eur. Heart J., December 2, 2005; 26(24): 2733 - 2741. [Abstract] [Full Text] [PDF] |
||||
![]() |
R C Welsh and P W Armstrong It's a matter of time: contemporary pre-hospital management of acute ST elevation myocardial infarction Heart, December 1, 2005; 91(12): 1524 - 1526. [Full Text] [PDF] |
||||
![]() |
H. Thiele, L. Engelmann, K. Elsner, M. J. Kappl, W.-H. Storch, K. Rahimi, A. Hartmann, D. Pfeiffer, G. D. Kneissl, D. Schneider, et al. Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction Eur. Heart J., October 1, 2005; 26(19): 1956 - 1963. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, S. Silber, P. Albertsson, F. F. Aviles, P. G. Camici, A. Colombo, C. Hamm, E. Jorgensen, J. Marco, J.-E. Nordrehaug, et al. Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Eur. Heart J., April 2, 2005; 26(8): 804 - 847. [Full Text] [PDF] |
||||
![]() |
N. Danchin Percutaneous coronary intervention following intravenous fibrinolytic therapy: should it be a must? Eur. Heart J., March 2, 2005; 26(6): 529 - 531. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |